CSIMarket


Pdl Biopharma, Inc.  (PDLI)
Other Ticker:  
 
    Sector  Healthcare    Industry Biotechnology & Drugs
   Industry Biotechnology & Drugs
   Sector  Healthcare


 

Pdl Biopharma, Inc.

PDLI's Financial Statements and Analysis



Pdl Biopharma, Inc. narrowed III. Quarter net loss per share of $-0.16 compare to net loss per share of $-0.76 recorded in the same quarter a year ago a decrease compare to $-0.04 realized in previous quarter.


III. Quarter
Earnings Per Share Revenues
$ -0.16 $  44 Mill
$+0.60     $-2M     -5.17 %



Pdl Biopharma's Revenue fell by -5.17 % in III. Quarter (Sep 30 2019) year on year, to $44 million and advanced by sequentially.


Pdl Biopharma is

More on PDLI's Income Statement



Pdl Biopharma's in III. Quarter recorded net loss of $-18 million, an improvement compare to net loss of $-112 million in II. Quarter a year ago.

Sequentially net loss advanced

More on PDLI's Growth

Inventories grew by 41.49 % to $21 million from II. Quarter a year ago, sequentially inventories rose by 28.77 %. PDLI's Cash flow In III. Quarter company's net cash flow was $9 million, capital expenditures grew by 18.36%, to $26 millions compare to same quarter a year ago and rose by -166.67% from II. Quarter (Jun 30 2019).

More on PDLI's Cash flow Statement


Pdl Biopharma, Inc. does not pay out common stock dividend.

In trailing twelve-month period Pdl Biopharma, Inc. earned $ 0.06 cash per share, on a free-cash flow basis 57.15 % of net earning per share.

Book value grew by 0.29 % sequentially to $5.64 per share, 829.82% of net income per share in trailing twelve-month period were contributed to shareholder value.
Tangible Book value grew to $ 5.22 per share from $ 5.20.

Company repurchased 5.30 million shares or 4.48 % in III. Quarter.
Interest Coverage Ratio was 4.6. Debt Coverage Ratio was 0.43.

More on PDLI's Dividends

 Market Capitalization (Millions) 353
 Shares Outstanding (Millions) 113
 Total Debt (Millions $) 132
 Revenue (TTM) (Millions $) 135
 Net Income (TTM) (Millions $) 19
 Cash Flow (TTM) (Millions $) 31
 Capital Exp. (TTM) (Millions $) 19
 Dividend TTM ($) 0 $
 Dividend Yield TTM (%) -
 Employees (TTM) $ -




Pdl Biopharma, Inc. does not pay out common stock dividend.

In trailing twelve-month period Pdl Biopharma, Inc. earned $ 0.06 cash per share, on a free-cash flow basis 57.15 % of net earning per share.

Book value grew by 0.29 % sequentially to $5.64 per share, 829.82% of net income per share in trailing twelve-month period were contributed to shareholder value.
Tangible Book value grew to $ 5.22 per share from $ 5.20.

Company repurchased 5.30 million shares or 4.48 % in III. Quarter.
Interest Coverage Ratio was 4.6. Debt Coverage Ratio was 0.43.

More on PDLI's Balance Sheets

 Market Capitalization (Millions) 353
 Shares Outstanding (Millions) 113
 Total Debt (Millions $) 132
 Revenue (TTM) (Millions $) 135
 Net Income (TTM) (Millions $) 19
 Cash Flow (TTM) (Millions $) 31
 Capital Exp. (TTM) (Millions $) 19
 Dividend TTM ($) 0 $
 Dividend Yield TTM (%) -
 Employees (TTM) $ -


   



             
Economy


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

Stocks


Event Calendar

SMGI's Profile

Stock Price

SMGI's Financials

Business Description

Fundamentals

Charts & Quotes

SMGI's News

Suppliers

SMGI's Competitors

Customers & Markets

Economic Indicators

SMGI's Growth

Company Segments

Screening


Stock Performance

Growth Rates

Profitability

Valuation

Dividend

Financial Strength

Efficiency

Largest Companies

Management Effectivness

Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

Markets


At a Glance

Stocks

Indices

Sectors & Industries

Financials

Commodities

Currencies

News


At a Glance

Stocks

Economy

Industries

Other

Help


Sitemap

Advertise

About us

Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.  Free Stock Market News Feeds
   Copyright © 2019 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

To view Intraday Stock Data Java must be installed. Java content may be prohibited by the security software, to see the stock quotes, choose "allow content from this page" option. Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071